Samsara (NYSE:IOT) stockholders approved all three proposals presented at the company’s fiscal 2027 annual meeting, including the election of eight directors, ratification of the company’s auditor and advisory approval of executive compensation, according to preliminary voting results announced during the meeting. The virtual meeting was called to order by Adam Eltoukhy, Samsara’s Executive Vice President, […]

Seres Therapeutics (NASDAQ:MCRB) held its reconvened 2026 Annual Meeting of Stockholders on July 8, with stockholders approving all five proposals presented at the meeting, according to the company’s preliminary vote report. Tom DesRosier, Executive Vice President, Chief Legal Officer and Secretary of Seres Therapeutics, chaired the meeting. He said the company had a quorum present, […]